Moreno Menghini

1.3k total citations
43 papers, 902 citations indexed

About

Moreno Menghini is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Moreno Menghini has authored 43 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Ophthalmology, 17 papers in Molecular Biology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Moreno Menghini's work include Retinal Diseases and Treatments (28 papers), Retinal Development and Disorders (15 papers) and Glaucoma and retinal disorders (12 papers). Moreno Menghini is often cited by papers focused on Retinal Diseases and Treatments (28 papers), Retinal Development and Disorders (15 papers) and Glaucoma and retinal disorders (12 papers). Moreno Menghini collaborates with scholars based in Switzerland, Australia and United Kingdom. Moreno Menghini's co-authors include Fred K. Chen, Danuta M. Sampson, David A. Mackey, David D. Sampson, Peijun Gong, Jacque L. Duncan, Di An, Daniel Barthelmes, M. Kurz–Levin and Florian Sutter and has published in prestigious journals such as PLoS ONE, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Moreno Menghini

41 papers receiving 883 citations

Peers

Moreno Menghini
Emin Özmert Türkiye
Yannek I. Leiderman United States
Igor Kozak Saudi Arabia
Mengxi Shen United States
Alon Skaat Israel
Georg Spital Germany
Emin Özmert Türkiye
Moreno Menghini
Citations per year, relative to Moreno Menghini Moreno Menghini (= 1×) peers Emin Özmert

Countries citing papers authored by Moreno Menghini

Since Specialization
Citations

This map shows the geographic impact of Moreno Menghini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moreno Menghini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moreno Menghini more than expected).

Fields of papers citing papers by Moreno Menghini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moreno Menghini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moreno Menghini. The network helps show where Moreno Menghini may publish in the future.

Co-authorship network of co-authors of Moreno Menghini

This figure shows the co-authorship network connecting the top 25 collaborators of Moreno Menghini. A scholar is included among the top collaborators of Moreno Menghini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moreno Menghini. Moreno Menghini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfau, Maximilian, Gabriela Grimaldi, Samuel Koller, et al.. (2025). Autosomal dominant RP1 c.2613dupA (p.Arg872Thrfs*2) variant retinitis pigmentosa shows linear loss of the ellipsoid zone over time with highly variable phenotype.. Ophthalmologica. 248(3). 1–16. 1 indexed citations
2.
Grimaldi, Gabriela, et al.. (2024). Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study. International Journal of Retina and Vitreous. 10(1). 70–70. 5 indexed citations
3.
Paris, A., et al.. (2024). One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration. Ophthalmology and Therapy. 13(11). 2985–2997. 5 indexed citations
4.
Beltraminelli, Tim, et al.. (2023). Comparison of visual performances of enhanced monofocal versus standard monofocal IOLs in a mini-monovision approach. BMC Ophthalmology. 23(1). 170–170. 14 indexed citations
5.
Koller, Samuel, Tim Beltraminelli, Silke Feil, et al.. (2023). Functional Analysis of a Novel, Non-Canonical RPGR Splice Variant Causing X-Linked Retinitis Pigmentosa. Genes. 14(4). 934–934. 4 indexed citations
6.
Grimaldi, Gabriela, et al.. (2023). Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(4). 1151–1159. 22 indexed citations
7.
Menghini, Moreno, Jasleen K. Jolly, Anika Nanda, et al.. (2020). Early Cone Photoreceptor Outer Segment Length Shortening in RPGR X-Linked Retinitis Pigmentosa. Ophthalmologica. 244(4). 281–290. 15 indexed citations
8.
Jolly, Jasleen K., et al.. (2020). Inner retinal thickening affects microperimetry thresholds in the presence of photoreceptor thinning in patients with RPGR retinitis pigmentosa. British Journal of Ophthalmology. 106(2). 256–261. 12 indexed citations
9.
Chen, Fred K., et al.. (2018). Intrasession Repeatability and Interocular Symmetry of Foveal Avascular Zone and Retinal Vessel Density in OCT Angiography. Translational Vision Science & Technology. 7(1). 6–6. 37 indexed citations
10.
Menghini, Moreno & Jacque L. Duncan. (2014). Diagnosis and Complementary Examinations. Developments in ophthalmology. 53. 53–69. 7 indexed citations
11.
Duncan, Jacque L., Pooja Biswas, Igor Kozak, et al.. (2014). Ocular Phenotype of a Family with FAM161A-associated Retinal Degeneration. Ophthalmic Genetics. 37(1). 1–9. 15 indexed citations
12.
Menghini, Moreno, Brandon J. Lujan, Shiri Zayit‐Soudry, et al.. (2014). Correlation of Outer Nuclear Layer Thickness With Cone Density Values in Patients With Retinitis Pigmentosa and Healthy Subjects. Investigative Ophthalmology & Visual Science. 56(1). 372–381. 58 indexed citations
13.
Kloeckener‐Gruissem, Barbara, Moreno Menghini, Florian Sutter, et al.. (2012). Long-term Studies On The Anti-VEGF Treatment Success In Age-related Macular Degeneration (amd). Investigative Ophthalmology & Visual Science. 53(14). 5168–5168. 2 indexed citations
14.
Menghini, Moreno, Stephanie L. Watson, & Martina M. Bosch. (2012). Corneal Melting Two Weeks after Pterygium Excision with Topical Mitomycin C: Successfully Treated with Lamellar Keratoplasty and Amnion Membrane Transplantation. Case Reports in Ophthalmology. 3(1). 24–29. 11 indexed citations
15.
Grimm, Christian, Daniel Barthelmes, Florian Sutter, et al.. (2012). Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD). AGE. 35(5). 1651–1662. 5 indexed citations
16.
Kloeckener‐Gruissem, Barbara, Moreno Menghini, Daniel Barthelmes, et al.. (2011). A Swiss Patient Cohort Reveals Genetic Predisposition Of Known And New Genetic Loci To AMD And To Intravitreal Ranibizumab (lucentis®) Treatment Outcome. Investigative Ophthalmology & Visual Science. 52(14). 5249–5249. 2 indexed citations
17.
Menghini, Moreno, et al.. (2011). Efficacy of Infliximab Therapy in Two Patients with Sympathetic Ophthalmia. Klinische Monatsblätter für Augenheilkunde. 228(4). 362–363. 8 indexed citations
18.
Menghini, Moreno, et al.. (2010). Response to Ranibizumab Therapy in Neovascular AMD – An Evaluation of Good and Bad Responders. Klinische Monatsblätter für Augenheilkunde. 227(4). 244–248. 23 indexed citations
19.
Menghini, Moreno, Florian Sutter, Daniel Barthelmes, et al.. (2007). Besteht ein Zusammenhang zwischen einer Kataraktoperation und nachfolgender exsudativer altersbedingter Makuladegeneration? Eine große retrospektive Fallkontrollstudie. Klinische Monatsblätter für Augenheilkunde. 224(4). 288–291. 2 indexed citations
20.
Sutter, Florian, Moreno Menghini, Daniel Barthelmes, et al.. (2007). Is Pseudophakia a Risk Factor for Neovascular Age-Related Macular Degeneration?. Investigative Ophthalmology & Visual Science. 48(4). 1472–1472. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026